Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA advisory about deadly risks associated with Kratom

SILVER SPRING, Md., Nov. 14, 2017 -- (Healthcare Sales & Marketing Network) -- The FDA is concerned about harmful unapproved products that have been crossing our borders in increasing numbers. The agency has a public health obligation to act when we see p... Biopharmaceuticals, FDA FDA, Kratom
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news